| Lance Liotta | |
| Birth Date: | 12 July 1947 |
| Birth Place: | Cleveland, Ohio[1] |
| Fields: | Biology |
| Workplaces: | George Mason University |
| Education: | Hiram College Case Western Reserve University |
| Thesis Title: | System dynamics of the hematogenous metastatic process from an implanted tumor |
| Thesis1 Url: | and |
| Thesis2 Url: | )--> |
| Thesis Year: | 1974 |
| Doctoral Advisors: | )--> |
| Known For: | Autocrine motility factor |
| Awards: | National Lectureship Award from the American Association for Clinical Chemistry (1987) |
| Spouses: | )--> |
| Partners: | )--> |
Lance A. Liotta (born July 12, 1947)[2] is the co-director and co-founder of the Center for Applied Proteomics and Molecular Medicine (CAPMM) at George Mason University.[3] His research team was the first to propose the existence of the autocrine motility factor. In 1985, he received the Rhoads Award (since renamed the Award for Outstanding Achievement in Cancer Research) from the American Association for Cancer Research. In 1987, he received the National Lectureship Award from the American Association for Clinical Chemistry. His other awards include the Warner-Lambert Parke Davis Award and the Surgeon General's Medallion.[1] [3]
The House of Representatives oversight subcommittee in 2004 provided evidence that Lance A. Liotta, then a researcher at the National Cancer Institute, had continued to receive thousands of dollars in compensation from a business arrangement through May, 2004, despite his testimony under oath the previous month that he had suspended the collaboration months before.[4]